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July 2013 not recapitulate the human disease, we, therefore, decided to induce experimentally vascular dissections or ruptures in young adults Col3a1 +/ − and Col3a1 +/+ BALB/c mice, to investigate whether Col3a1 +/ − mice are more susceptible to vascular ruptures than wild-type mice as observed in vEDS patients. Among the different experimental methods developed to study the formation and progression of vascular disease, the chronic infusion of angiotensin II (AngII) has consistently been used as a model of aortic dissections and arterial ruptures notably in hypercholesterolemic mice. 15 , 16 Chronic infusion of AngII through the use of osmotic mini-pumps induced a rapid and severe premature lethality in Col3a1 +/ − mice caused by thoracic aortic dissections and ruptures. Aortic ruptures were correlated with signifi cantly less collagen fi brils production in early deceased Col3a1 +/ − mice compared with Col3a1 +/ − mice which survived longer. We further showed that this may have conferred to Col3a1 +/ − TAs, an important fragility in response to AngII toxicity and its associated rises in blood pressure (BP) as the incidence of early complications was signifi cantly reduced when lowering BP or when infusing another agonist with comparable pressor effect.
Methods
A detailed description of all methods is presented in the online-only Data Supplement.
Results

Basal Characterization of Col3a1 +/− Mice
We fi rst evaluated in young adult Col3a1 +/ − and Col3a1 +/+ BALB/c mice different basal systemic and vascular parameters reported in Table S1 in the online-only Data Supplement. Basal systolic BP (SBP) was slightly decreased in Col3a1 +/ − mice compared with Col3a1 +/+ mice, with no modifi cation in their heart rate values. Aortic diameters of TA and AA, as well as their respective media thicknesses, were comparable between both groups of mice, although adventitial collagen content was lower in Col3a1 +/ − aortas compared with Col3a1 +/+ aortas. Consistently, histological colorations of aortic sections showed normal vascular wall rearrangement in both groups of mice as previously reported 12 ( Figure S1 ). As expected, type III collagen mRNA expression was signifi cantly reduced by ≈ 50% in TA and AA of Col3a1 +/ − mice compared with Col3a1 +/+ mice (Table S2) . However, mRNA expression of type I collagen and metalloproteinase types 2 and 9 (MMP-2 and MMP-9) remained unchanged in Col3a1 +/ − mice compared with Col3a1 +/+ mice.
Chronic Infusion of AngII Leads to Sudden and Premature Deaths in Col3a1 +/ − Mice
AngII mini-pumps (1 μ g/kg per minute during 28 days) were implanted in Col3a1 +/ − and Col3a1 +/+ mice (n=11 mice in each group). AngII infusion induced lethality in both groups of mice ( Figure 1A ). However, mortality was more rapid and dramatic in Col3a1 +/ − mice when compared with Col3a1 +/+ mice. During the fi rst week of infusion, 55% of Col3a1 +/ − mice died versus 0% in Col3a1 +/+ group. At the end of the 28-day period of infusion, our results showed a 73% versus a 36% mortality rate in Col3a1 +/ − and Col3a1 +/+ mice, respectively (logrank test, P =0.03). For both groups, AngII infusion induced a rapid and signifi cant increase in SBP during the 28-day period ( P =10 − 10 compared with basal SBP; Figure 1B ). The magnitude of the hypertension and the percentage in survival rates observed in the wild-type mice are in accordance with what was previously reported in BALB/c mice in response to chronic AngII infusion. 17 Importantly, SBP was comparable between the 2 groups of mice over the 28-day period ( P =0.64). However, over the same period of time, heart rate was signifi cantly reduced in Col3a1 +/ − when compared with Col3a1 +/+ mice ( P =0.001). Remarkably, during the fi rst week of infusion, early deaths occurred in Col3a1 +/ − mice with the highest rises in SBP ( Figure S2 ).
Premature Deaths in Col3a1 +/ − Mice Are Caused by Thoracic Aortic Ruptures and Can Be Preceded by Aortic Dilatations
Using echocardiography, we were able to measure in vivo aortic diameters of the 11 Col3a1 +/ − and the 11 Col3a1 +/+ mice, before and during the AngII infusion experiment described above ( Figures S3 and S4 ). Interestingly, days during which we noticed the appearance of an aortic dilatation just preceded death of the corresponding mouse. In Col3a1 +/ − mice, 5 aortic dilatations were observed, both in the ascending and in the suprarenal regions, and among them 3 corresponded to early deceased mice (at days 2, 4, and 11; Figure S3 ). Thus, ≈ 37% of early dead mice in this group (3/8 mice) did exhibit aortic dilatations before their death.
Location of these aortic dilatations matched the autopsy and the histological observations that followed. At autopsy of Col3a1 +/ − mice, only hemothorax were observed, suggesting that all death cases probably ended in ruptures of the TA. Detailed analysis showed that large hematomas were predominantly observed surrounding the heart at the aortic root and arch and some were also observed in the descending TA (close to the thoraco-abdominal junction; Table) . Even if we were unable to determine the precise site of aortic rupture for each death case, histological analysis evidenced that all premature deaths could be associated with major thoracic aortic dissections. 75% of them were more prominent in the ascending aorta (aortic arch) rather than in the descending aorta of Col3a1 +/ − mice (Table) . Hematoxylin/eosin staining showed that major dissections were often represented by massive intramural hematomas particularly located beneath the external elastic lamina ( Figure 2 ). Orcein and Col3a1 +/+ mice ( Figure S7 ) and to the same extent as previously reported. 18 To examine the concomitant fi brotic effect of AngII which could, if altered, explain the aortic fragility of Col3a1 +/ − TA, we quantifi ed vascular collagen content in AngIIinfused Col3a1 +/ − and Col3a1 +/+ mice using their thoracic aortic sections stained with Picro-Sirius red ( Figure 3A ) . Early ruptured Col3a1 +/ − aortas (before day 5) had a lower collagen content compared with those examined after 2 to 4 weeks of AngII exposure, as illustrated by the scatter-plot graphs ( Figure 3B ). Indeed, early ruptured aortas failed to increase their collagen content in the adventitia compared with basal condition ( P =0.48) and in contrary to surviving mice which succeeded in increasing signifi cantly their level of adventitial collagen in response to AngII ( P =0.04 when compared with early dead mice; Figure  S8 ). Compared with basal condition, early dead mice were, however, able to signifi cantly increase their collagen content in response to AngII in the media layer ( P =0.02), but at a much lower degree (100 × less) than the surviving mice ( P =0.05 when compared with early dead mice). Importantly, we further showed that Col3a1 +/ − TA were indeed unable to signifi cantly increase their levels of collagens mRNA after 5 days of AngII infusion, in contrary to Col3a1 +/+ TA (Table S3) . Interestingly, for each Col3a1 +/ − mouse, collagen content of the media layer correlated with the corresponding media thickness ( Figure S9 ). In contrast to what was observed in TA, AngII signifi cantly increased collagen fi brils formation in the adventitia layer of AA from early dead Col3a1 +/ − mice ( P =0.01) and this time to a comparable level with surviving Col3a1 +/ − mice ( P =0.07; Figure S10 ).
BP Contribution to AngII-Induced Aortic Ruptures
To precise the respective contribution of BP and AngII toxicity per se on premature deaths, we tested a chronic infusion of either a lower dose of AngII (0.5 μ g/kg per minute; n=10 mice per group; Figure 4A ) or norepinephrine (NE; 3.9 μ g/kg per minute; n=8 mice per group; Figure 4B ), expecting similar rises in BP with 2 different mechanisms. 18 , 19 We used linear mixed-effects models approach (see Methods for details), to compare SBP among the 3 different pharmacological treatments (high-dose of AngII, low-dose of AngII, and NE). Our data showed that for both groups of mice, low-dose of AngII and NE infusions induced a signifi cant increase in SBP over the 28-day period of infusion when compared with their respective basal SBP ( P =2 × 10 − 9 and P =0.0009, respectively; Figure S11 ). Rises in SBP were similar between these 2 treatments within each group of mice ( P =1.00 in each group of mice) and were also comparable between the 2 groups of mice within each treatment ( P =0.53 and P =1.00, respectively, for the low-dose of AngII and the NE experiments). Despite these similar increases in SBP, NE and low-dose AngII did not induce the same lethality ( Figure 4A and 4B , red lines). NE failed to induce premature lethality in contrast to the lowdose of AngII which induced a signifi cant and comparable mortality rate in both groups of mice (30% and 50% in Col3a1 +/ − and Col3a1 +/+ mice, respectively; logrank test, P =0.30). In Col3a1 +/ − mice, the lethality was signifi cantly reduced under the low-dose of AngII compared with the high-dose of AngII (logrank test, P =0.01), particularly during the fi rst week of infusion. SBP was also signifi cantly reduced during the fi rst week of infusion under the low-dose infusion compared with the high-dose infusion ( P =0.05). Therefore, lowering the dose of AngII and its associated rises in SBP rescued the premature mortality observed in Col3a1 +/ − mice during the fi rst week of infusion. Importantly, in Col3a1 +/ − mice, SBP was ). SBP was comparable between both groups of mice ( P =0.64) but HR was signifi cantly lower in Col3a1 +/ − mice compared with Col3a1 +/+ mice ( P =0.001). Data are mean ± SEM. * P ≤ 0.05 and * * P ≤ 0.01 when daily SBP were compared with basal SBP within each group of mice. 
Discussion
This study evidences for the fi rst time the arterial fragility of Col3a1 insuffi cient mice and their susceptibility to develop thoracic aortic dissections and ruptures in response to AngII. As observed in vEDS patients, in this AngII infusion model, Col3a1 +/ − mice died prematurely and signifi cantly more when compared with Col3a1 +/+ mice. The haploinsuffi ciency in type III collagen confers an important fragility to the thoracic aortic wall in response to rapid and important rises in SBP induced by a high-dose of AngII. In this model, BP seems to be a major trigger of this fragility since (1) early deceased Col3a1 +/ − mice had also the highest rises in SBP, and (2) lowering by half the dose of AngII and its associated increases in SBP (26 to 13 mm Hg) rescued the fi rst-week premature deaths observed in Col3a1 +/ − mice. This is consistent with the contribution of collagen to the mechanical properties of the arterial wall and the preponderance of type III collagen in the media. However,
NE infusion in Col3a1
+/ − mice also increased SBP during the fi rst-week infusion, and comparably with the low-and with the high-dose of AngII, but did not induce premature mortality. This favors the hypothesis of AngII toxicity per se, independently of BP, to be critical in the occurrence of arterial ruptures in this model and possibly also in vEDS patients.
Concomitantly to arterial hypertension, AngII induces vascular remodeling 20 through smooth muscle cell hypertrophy and secretion of proteins of the extracellular matrix, which if altered could contribute to aortic fragility. Indeed, we showed that TA from Col3a1 +/ − mice failed to increase signifi cantly their levels of collagens expression in response to 5 days of AngII infusion, in contrast to wild-type mice. In addition, Col3a1 +/ − mice not only possessed less aortic collagen fi brils in basal condition compared with wildtype mice but their early ruptured TAs had a lower production in aortic collagen in response to AngII compared with mice that survived longer. Aortic collagen content corresponds to mature cross-linked type I collagen fi brils, formed of type I and type III collagens. As type III collagen is crucial for type I collagen fi brillogenesis, 11 the haploinsuffi ciency in type III collagen could thus also brake the time-course in collagen fi brils formation, thereby increasing the intrinsic arterial +/ − mice which deceased at day 3 after AngII infusion. Images show that the dissection was present within the arch of the ascending aorta. Serial cross-sections enabled us to observe that this dissection was more developed along the proximal part of the descending aorta ( ) rather than toward the aortic root ( ▲ ) where there is no sign of dissection. Zoom on the dissected area showed breaks in elastic fi bers (dotted arrows) and major blood infi ltration within and outside the media layer. The second lane corresponds to the same mouse as the one represented in the top . The pattern and the extent of the dissections confi rmed well that the descending aorta is severely affected in this mouse. Bottom , Images represent a major dissection (indicated by black dashed arrows) formed along the descending aorta of another Col3a1 +/ − mice dead at day 11 after AngII infusion (illustrated in Figure S3 ). Colorations showed net fragmentation of elastic fi bers (dotted arrows) and blood infi ltration within the media layer. by guest on July 8, 2017 http://hyper.ahajournals.org/ Downloaded from fragility of Col3a1 +/ − mice. Another important observation of our study was that premature mortality of Col3a1 +/ − mice was due to dissections and ruptures that occur predominantly in TA rather than in AA. Strikingly, reduction in (pro α 1-) type I collagen in mice lead to similar aortic pathology as the one observed in Col3a1 +/ − mice. 21 In these mice, early deaths were correlated with aortic dissections (also associated with less adventitial collagen), whereas the histology of other large vessels remained normal. Even if Rahkonen et al 21 were unable to determine the precise site of aortic ruptures for each individual death case, they observed in some cases that the origin of the dissections was close to the aortic root. Thus, it seems that both collagens are critical in the pathogeny of aortic dissections and ruptures, specifi cally in the ascending aorta, a lesion-prone segment likely associated with highly variable shear and wall stress patterns. More recently, mice bearing deletion of a region of chromosome 1 have unexpectedly been correlated with a predicted null allele of the Col3a1 gene. 22 Interestingly, these mutant mice exhibited a phenotype which closely resembles to that of our AngII-induced phenotype in Col3a1 +/ − mice, such as premature deaths associated with dissections and ruptures of the ascending or descending TA. Taken together, this indicated that type III collagen plays a major role in TA integrity rather than in AA and reveals important possible pathogenic differences between TA and AA as it has been already evoked. 23 In conclusion, we demonstrated for the fi rst time that chronic AngII infusion in Col3a1 +/ − mice induced thoracic aortic dissections and ruptures which may be preceded by aneurysms, thus leading to premature and sudden death. These thoracic aortic ruptures were associated with a low production in collagen fi brils which might confer an important fragility to this 
Perspectives
A majority of human vEDS cases are caused by missense mutations (glycine substitutions) in COL3A1 gene, but cases of COL3A1 haploinsuffi ciency caused by specifi c mutations have also been reported. 4 Primary complications of these patients are only limited to vascular complications (ruptures, dissections, or aneurysms), with a majority of dissections affecting notably AA and TA. These ruptures might be favored by rapid changes in BP. Therefore, despite the inherent
+/ − mice may also help to gain further insights in the pathogenesis of the overall progression of arterial disease in vEDS.
Supplemental Methods
Animals
Col3a1
+/-mice [strain C.129S4(B6)-Col3a1tm1Jae/J SN290] were originally purchased on a BALB/c genetic background from Charles River Laboratories (L'arbresles, France). For all animal studies, we solely used young adult males littermates from wild-type (Col3a1
+/-mice were maintained on a BALB/c genetic background in our mouse facility.
Drug Infusion and Treatments
Angiotensin II (AngII) (dissolved at the dose of 1µg/kg/min or 0.5µg/kg/min in saline solution) and norepinephrine (NE) (dissolved at the dose of 3.9µg/kg/min in saline solution with 0.2% wt/vol L-ascorbic acid) were used to fill osmotic mini-pump (model ALZET 2004) as previously described 1,2 . For each individual series of drug infusion experiments, young males littermates from Col3a1 +/-(n=8 to 11) and Col3a1 +/+ (n=8 to 11) mice had comparable ages (from 9 to 12 weeks) and weights (from 23g to 28g) (P>0.05 between groups for weeks and weights comparison within each single series). Filled mini-pumps were, before implantation, equilibrated 24 hours to 48 hours in saline solution, at 37°C. They were then implanted subcutaneously in the back of the mouse previously anesthetized with isoflurane (2%). Surviving mice were all sacrificed at day 28 of AngII infusion.
Systolic Blood Pressure Measurement
Systolic Blood Pressure (SBP) and Heart Rate (HR) were measured on conscious Col3a1 +/-and Col3a1 +/+ mice using a tail cuff system (BP-2000 Visitech Systems) as described previously 3 . Measurements were always performed in the morning. For each animal, the system automatically performed 4 first measurements which were not recorded; then, 10 consecutive measurements of SBP and HR were recorded for each mouse (leading to 10 or less SBP and HR values for each mouse). For our analysis, we only kept SBP and HR measurements for which we had at least 4 (out of 10) values. To avoid procedure-induced anxiety, and for each series of experiments, mice were initially accustomed to the tail cuff system during 3 consecutive days. Then, basal SBP and HR were recorded during 2 to 3 days (which were averaged) just prior mini-pump implantations. At the end of our study, we obtained a total number of n=38 to 40 mice in each group for which we had basal SBP recordings. Next, for each single series of experiments, SBP and HR were systematically measured at days 1, 2, 3, 4, 7, 13 or 14, 20 or 21 and 28, post-implantation.
Echocardiography
Echocardiography was performed using a Vevo 2100 imaging system and a MS400 (18-38 MHz) transducer (VisualSonics Inc, Toronto Ontario, Canada). The resolution for this device is 30 microns. Mice were sedated in a chamber using isoflurane, 2.0% to 2.5% for induction and maintenance. Mice were shaved from the thorax to the lower abdominal region. Ultrasound transmission gel (Aquasonic 100; Parker Laboratories, Inc, Fairfield, NJ) was applied onto the shaved region of interest. The thoracic aortic arch was imaged along its long-axis using a modified right parasternal transthoracic view, the thoracic aorta behind the cardiac structures using a modified long-axis parasternal transthoracic view and the suprarenal aorta using an abdominal longitudinal view. Two-dimensional guided colour Doppler helped to target vessel confirmation. Measurements of the systolic diameters of the aorta (using "leading edge to leading edge" technique) were performed offline on digitally stored recorded cine loops at three different levels: one measurement was performed at the level of the ascending aorta, another at the level of the descending aorta and a third one at the level of the suprarenal abdominal aorta, by a single observer blinded to the genotype of the mice. Measurements were performed before (day 0) and throughout AngII infusion at days 1, 2, 4, 7, 14 and 28. Basal aortic diameters at day 0 reported in Table 1 are the mean of one measurement per mice in n=11 mice in each group. During AngII infusion, when aortic dilatation was observed in one of these regions, its maximal diameter was then reported (in the graphs from Supplemental Figures S3 and S4 ) to illustrate the occurrence and the progression of a dilatation and/or dissection. It has been shown that the variability of in vivo measurements derived from this technique applied to aneurysmal and nonaneurysmal aortas is in the order of 0.1 to 0.01 mm, with excellent agreement between measurements regardless of the size or region of the aorta evaluated 4 .
Tissue collection and Morphometric analyses
Col3a1 +/-and Col3a1 +/+ mice from drug infusion experiments were either dissected within the 24 hours after death observation in case of premature death or sacrificed at day 28 of drug infusion if they survived. An additional group of mice representing our control group for basal condition was used for basal histological and quantification analysis only. All mice were sacrificed with a lethal dose of 20% sodium pentobarbital (i.p.) and a midsternal thoracotomy was performed. Heart, thoracic and abdominal aortas were carefully exposed. Heart and thoracic aorta connected to each other and abdominal aortas (from renal to iliac junctions) were isolated and fixed in 4% paraformaldehyde. Before paraffin inclusion, heart was dissociated from the thoracic aorta at the junction between ascending and descending aorta. Then thoracic (TA) and abdominal (AA) aortas were, each of them, cut into 2 to 3 pieces. Each fragment was embedded in paraffin and aortic cross-sections of 6µm were obtained using a microtome. Aortic cross-sections were stained with hematoxylin/eosin, orcein or Picro-Sirius red solutions for imaging and morphometric measurements. Media thicknesses of TA and AA were calculated from orcein stained cross-sections using Archimed software (Microvision Instruments, France). We used 3 to 6 serial cross-sections for each mouse to perform our measurements. Aortic serial cross-sections were chosen in non symptomatic regions, i.e. non affected by important dissections or ruptures, in order to have the most rigorous estimation of the media thickness. For each cross-section, we performed 10 measurements of the media thickness between the internal and the external elastic lamina. Thus, each mouse has one mean value calculated from 30 to 60 measurements. Measurements were performed by a single individual blinded to the genotype of the animals. Concerning the additional group of mice representing our control group for basal condition, these Col3a1 +/-(n=5) and Col3a1 +/+ (n=5) mice had also comparable ages (10.3 and 11.4 weeks respectively; P>0.05), and did not receive any drug or treatment infusion.
Collagen content quantification
Collagen content of TA and AA aortic wall were measured from aortic cross-sections stained with Picro-Sirius red observed through polarized light using AxioVision® and a Zeiss microscope at 2.5X magnification as described previously 5 . Under these conditions, total collagen appears in red and represents mature type I collagen fibrils (formed of type III and type I collagens). We used the Leica Qwin® software to quantify the collagen content both in the adventitia and the media layers. We performed measurements of the surface of the media and the adventitia layers as well as measurements of the quantity of total collagen, both expressed in arbitrary units. Then collagen content can be expressed in arbitrary units as well as in % of the surface of interest (media or adventitia). We used 1 cross-section for each mouse to perform our quantifications. Measurements were performed by a single investigator blinded to the genotype of the animals. With our quantification technique, we were unable to detect collagen in the media layer of AA from both groups of mice. +/-and Col3a1 +/+ group). These mice did not receive any treatment but were sacrificed at the same time as the other group of mice. The increase in SBP and the survival rates that we obtained during the 5 days of AngII infusion were in accordance with what we showed in Figure 1 . At day 5 of infusion, AngIIinfused mice which did not die earlier, were all sacrificed (n=4 Col3a1 +/-and n=5 Col3a1 +/+ mice). Thoracic and abdominal aortas were isolated from every mouse, rapidly dissected and cleaned (by removal of vascular fat and connective tissue surrounding the vessel) in cold PBS. They were then snap-freezed in liquid nitrogen in order to be used for RNA extraction and quantitative-PCR as described above.
Real time Quantitative-Polymerase Chain Reaction (q-PCR)
Drugs and Reagents
Sodium pentobarbital (CEVA Santé animale, France); Osmotic mini pumps Model ALZET 2004 (Charles River Laboratories, France); L-ascorbic acid (cat number: W5408M, Fisher Scientific, France); Angiotensin II (cat number: A9525) and L-norepinephrine bitartrate salt (cat number: A9512) were purchased from SIGMA-ALDRICH (France).
Statistical analysis
All data are expressed as mean ± SEM. To compare SBP between the three different pharmacological treatments (high-dose AngII, low-dose AngII and NE) over the 28-days infusion period, we used linear mixed-effects models for variance analysis (type II sums of square). We also used a general linear model adapted to ANOVA two-way repeated measures to compare SBP and HR between Col3a1 +/-and Col3a1 +/+ mice, over the 28-days period of AngII or NE experiments. Normality and homoscedasticity were assessed before analysis. For all statistical tests performed, P≤0.05 was considered to be statistically significant. NS means that P>0.05, * means that P≤0.05 and ** means that P≤0.01 between two groups or two conditions. A student t-test for unpaired series was used to compare between Col3a1 +/-and Col3a1 +/+ mice: in vivo aortic diameters, basal media thickness, basal collagen content, q-PCR results, ages and weights of the mice, basal SBP and basal HR. A student t-test for paired series was used to compare within each group of mice, SBP measured daily during AngII or NE infusion to their respective SBP measured under basal condition (Figures 1 and S11) . Media thicknesses and collagen contents before and during AngII infusion were also compared using a student t-test for paired series within each group of mice (Figures S7, S8 and S10).
We used a general linear model adapted to ANOVA two-way repeated measures to compare SBP and HR between Col3a1 +/-and Col3a1 +/+ mice over the 28-days period of AngII or NE experiments (Figures 1 and S11) . To compare SBP between the three different pharmacological treatments (high-dose AngII, low-dose AngII and NE infusions) over the 28-days period (or over the first-week infusion only), we used linear mixed-effects models for variance analysis (type II sums of square). We used similar models to compare SBP over the 28-days period of treatment to its corresponding basal SBP (Figures 1 and S11) . Mouse was used as a random effects factor, whereas day, drug infusion (treatment) and group were taken as fixed effects factor; second order interaction between fixed effects factors were considered in the models. This analysis was performed using the R software (v. 2.13.0) 6 with additional packages nlme 7 , car 8 and multcomp 9 . Model assumptions, both on residuals and on random effects structure (including normality and homoscedasticity) were assessed before further analysis. Suited contrasts (ad hoc) were used to compare, over the 28-days period, the three different treatments on SBP and HR. Finally, we performed Kaplan-Meier survival analyses to draw and compare survival rates between the two groups and for each drug infusion condition. A Logrank (Mantel-Cox) test was used to calculate the statistical significance between two survival curves. 
Supplemental
Supplemental Figures
Supplemental Figure S1 . This experiment is representative of 2 independent experiments which both gave comparable results. The graph represents SBP (lower bars -left scale) and HR (upper lines -right scale) measured before (basal) and during AngII (0.5µg/kg/min) infusion. AngII infusion induced a significant increase in SBP over time for both groups (P=2x10 -9 ). SBP and HR were comparable between both groups of mice (P=0.53 respectively) throughout the duration of the treatment. Data are mean ± SEM. * means P≤0.05 and ** means P≤0.01 when daily SBP were compared to basal SBP within each group of mice. B-Norepinephrine (NE) infusion. Lower graph represents SBP (lower bars -left scale) and HR (upper lines -right scale) as a function of days of NE infusion. NE infusion led to a significant increase in SBP over time for both groups (P=0.0009). SBP and HR were comparable between both groups of mice (P=1.00 respectively) throughout the duration of the treatment. Data are mean ± SEM. * means P≤0.05 and ** means P≤0.01 when daily SBP were compared to basal SBP within each group of mice.
